Acetylcholinesterase monoclonal antibody-induced sympathectomy: Effects on immune status and acute morphine-induced immunomodulation

Brain, Behavior, and Immunity

Volumn 11, Issue 3, 1997, Pages 167-184

  Fecho, Karamarie ^a   Maslonek, Kimberly A ^a   Dykstra, Linda A ^a,b   Lysle, Donald T ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholinesterase monoclonal antibodies; IFN ; IL 2; Immune system; Immunomodulation; Mitogen stimulated proliferation; Morphine; Neuroimmunomodulation; NK cell activity; Psychoneuroimmunology; Rats; Sympathetic nervous system

Indexed keywords

ACETYLCHOLINESTERASE; GAMMA INTERFERON; IMMUNOGLOBULIN G2B; INTERLEUKIN 2; MITOGENIC AGENT; MONOCLONAL ANTIBODY; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHOLINERGIC NERVE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NONHUMAN; PREGANGLIONIC NERVE; PRIORITY JOURNAL; RAT; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPATHECTOMY; SYMPATHETIC NERVE; SYMPATHETIC TONE; T LYMPHOCYTE;

EID: 0031229325     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1997.0490     Document Type: Article

References (65)

1. Ader, R., Felten, D., & Cohen, N. (1990). Interactions between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol. 30, 561-601.
2. Appel, N. M., Kiritsy-Roy, J. A., & Van Loon, G. R. (1986). Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow. Brain Res. 378, 8-20.
3. Bayer, B. M., Daussin, S., Hernandez, M., & Irvin, L. (1990). Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29, 369-374.
4. Bayer, B. M., Gastonguay, M. R., & Hernandez, M. C. (1992). Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23, 117-124.
5. 2-adrenoceptor subtypes in rat brain. Biochem. Pharmacol. 37, 1145-1151.
6. Besedovsky, H. O., del Rey, A., Sorkin, E., Da Prada, M., & Keller, H. H. (1979). Immunoregulation mediated by the sympathetic nervous system. Cell. Immunol. 48, 346-355.
7. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovas. Pharmacol. 5, 430-437.
8. Brenner, G. J., Felten, S. Y., Felten, D. L., & Moynihan, J. A. (1992). Sympathetic nervous system modulation of tumor metastases and host defense mechanisms. J. Neuroimmunol. 37, 191-201.
9. Brimijoin, S., Hammond, P., Khraibi, A. A., & Tyce, G. M. (1994). Catecholamine release and excretion in rats with immunologically induced preganglionic sympathectomy. J. Neurochem. 62, 2195-2204.
10. Brimijoin, S., Moser, V., Hammond, P., Oka, N., & Lennon, V. A. (1993). Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of peripheral preganglionic sympathetic terminals by acetylcholinesterase antibodies. Neuroscience 54, 201-223.
11. Brimijoin, S., & Lennon, V. A. (1990). Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc. Natl. Acad. Sci. USA 87, 9630-9634.
12. Brimijoin, S., & Lennon, V. A. (1991). Selective destruction of preganglionic sympathetic nerves by antibodies to acetylcholinesterase. J. Neural Transm. 34(Suppl.), 139-145.
13. Byron, J. W. (1972). Evidence for a β-adrenergic receptor initiating DNA synthesis in haemopoietic stem cell. Exp. Cell Res. 71, 228-232.
14. Cabot, J. B. (1990). Sympathetic preganglionic neurons: Cytoarchitecture, ultrastructure, and biophysical properties. In A. D. Loewy & K. M. Spyer (Eds.), Central regulation of autonomie functions, pp. 44-67. Oxford Univ. Press: New York.
15. Carr, D. J. J., Gerak, L. R., & France, C. P. (1994a). Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice. J. Pharmacol. Exp. Ther. 269, 693-698.
16. Carr, D. J. J., Mayo, S., Gebhardt, B. M., & Porter, J. (1994b). Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J. Neuroimmunol. 53, 53-63.
17. Chen, G., Portman, R., & Wickel, A. (1951). Pharmacology of 1,1-dimethyl-4-phenylpiperazinium iodide, a ganglion stimulating agent. J. Pharmacol. Exp. Ther. 103, 330-336.
18. Crary, B., Borysenko, M., Sutherland, D. C., Kutz, I., Borysenko, J. Z., & Benson, H. (1983). Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans. J. Immunol. 130, 694-697.
19. Dagerlind, Å., Brimijoin, S., Goldstein, M., & Hökfelt, T. (1993). Effects of antibodies against acetylcholinesterase on the expression of peptides and catecholamine synthesizing enzymes in the rat adrenal gland. Neuroscience 54, 1079-1090.
20. Dagerlind, Å., Pelto-Huikko, M., Lundberg, J. M., Ubink, R., Verhofstad, A., Brimijoin, S., & Hökfelt, T. (1994a). Immunologically induced sympathectomy of preganglionic nerves by antibodies against acetylcholinesterase: Increased levels of peptides and their messenger RNAs in rat adrenal chromaffin cells. Neuroscience 62, 217-239.
21. Dagerlind, Å., Zhang, X., Brimijoin, S., Lindh, B., & Hökfelt, T. (1994b). Effects of preganglionic sympathectomy on peptides in the rat superior cervical ganglion. NeuroReport 5, 909-912.
22. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993). Multiple defects of immune cell function in mice with disrupted IFN-γ genes. Science 259, 1739-1742.
23. Deitch, E. A., & McIntyre Bridges, R. (1987). Stress hormones modulate neutrophil and lymphocyte activity in vitro. J. Trauma 27, 1146-1153.
24. Depelchin, A., & Letesson, J. J. (1981). Adrenaline influence on the immune response. I. Accelerating or suppressor effects according to the time of application. Immunol. Lett. 3, 199-205.
25. Fecho, K., Dykstra, L. A., & Lysle, D. T. (1993a). Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265, 1079-1087.
26. Fecho, K., Maslonek, K. A., Coussons-Read, M. E., Dykstra, L. A., & Lysle, D. T. (1994). Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152, 5845-5852.
27. Fecho, K., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1993b). Alterations of immune status induced by the sympathetic nervous system: Immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav. Immun. 7, 253-270.
28. Fecho, K., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1996a). Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276, 626-636.
29. Fecho, K., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1996b). Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277, 633-645.
30. Feldman, R. D., Hunninghake, G. W., & McArdle, W. L. (1987). β-adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J. Immunol. 139, 3355-3359.
31. Felten, D. L., Felten, S. Y., Carlson, S. L., Olschowka, J. A., & Livnat, S. (1985). Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135, 755s-765s.
32. Flores, L. R., Hernandez, M. C., & Bayer, B. M. (1994). Acute immunosuppressive effects of morphine: Lack of involvement of pituitary and adrenal factors. J. Pharmacol. Exp. Ther. 268, 1129-1134.
33. Freier, D. O., & Fuchs, B. A. (1994). A mechanism of action for morphine-induced immunosuppression: Corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Exp. Ther. 270, 1127-1133.
34. Fresa, K., Hameed, M., & Cohen, S. (1989). Intracellular mechanisms of lymphoid cell activation. Clin. Immunol. Immunopathol. 50, 8-19.
35. Gross, F. (1981). International experience with nadolol, a long-acting β-blocking agent. In Royal society of medicine international congress and symposium series, No. 37, pp. 8-38. Royal Society of Medicine/ Academic Press: London.
36. Hadden, J. W., Hadden, E. M., & Middleton, E., Jr. (1970). Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell. Immunol. 1, 583-595.
37. Hall, N. R., McClure, J. E., Hu, S.-K., Tare, N. S., Seals, C. M., & Goldstein, A. L. (1982). Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses. Immunopharmacology 5, 39-48.
38. Hernandez, M. C., Flores, L. R., & Bayer, B. M. (1993). Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267, 1336-1341.
39. Hodgkin, P. D., Yamashita, L. C., Coffman, R. L., & Kehry, M. R. (1990). Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J. Immunol. 145, 2025-2034.
40. Hoffman, K. E., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1995). Effects of central administration of morphine on immune status in lewis and wistar rats. In B. Sharp, T. Eisenstein, J. Madden, & H. Friedman (Eds.), The brain immune axis and substance abuse, pp. 155-159. Plenum Press: New York.
41. Kostrzewa, R. M., & Jacobowitz, D. M. (1974). Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26, 199-288.
42. Kruszewska, B., Felten, S. Y., & Moynihan, J. A. (1995). Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J. Immunol. 155, 4613-4620.
43. Lockwood, L. L., Silbert, L. H., Fleshner, M., Laudenslager, M. L., Watkins, L. R., & Maier, S. F. (1994). Morphine-induced decreases in in vivo antibody responses. Brain Behav. Immun. 8, 24-36.
44. Loveland, B. E., Jarrott, B., & McKenzie, I. F. C. (1981). The detection of β-adrenoceptors on murine lymphocytes. Int. J. Immunopharmacol. 3, 45-55.
45. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., & Dykstra, L. D. (1993). Morphine-induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265, 1071-1078.
46. Lyte, M., Ernst, S., Driemeyer, J., & Baissa, B. (1991). Strain-specific enhancement of splenic T cell mitogenesis and macrophage phagocytosis following peripheral axotomy. J. Neuroimmunol. 31, 1-8.
47. Madden, K. S., Felten, S. Y., Felten, D. Y., Sundaresan, P. R., & Livnat, S. (1989). Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy. Brain Behav. Immun. 3, 72-89.
48. Madden, K. S., Moynihan, J. A., Brenner, G. J., Felten, S. Y., Felten, D. L., & Livnat, S. (1994). Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunol. 49, 77-87.
49. Malhotra, R. K., & Wakade, A. R. (1987a). Non-cholinergic component of rat splanchnic nerves predominates at low neuronal activity and is eliminated by naloxone. J. Physiol. 383, 639-652.
50. Malhotra, R. K., & Wakade, A. R. (1987b). Vasoactive intestinal polypeptide stimulates the secretion of catecholamines from the rat adrenal gland. J. Physiol. 388, 285-294.
51. 2+ through breakdown of phosphoinositides to induce catecholamine secretion. J. Biol. Chem. 263, 2123-2126.
52. 3H-clonidine binding in membranes prepared from guinea-pig spleen. Clin. Exp. Pharmacol. Physiol. 9, 77-87.
53. Minneman, K. P., Pittman, R. N., & Molinoff, P. B. (1981). β-Adrenergic receptor subtypes: Properties, distribution, and regulation. Annu. Rev. Neurosci. 4, 419-461.
54. Parkinson, D. (1990). Adrenergic receptors in the autonomic nervous system. In A. D. Loewy & K. M. Spyer (Eds.), Central regulation of autonomic functions, pp. 17-27. Oxford Univ. Press, Inc.: New York.
55. Plummer, A. J., Trapold, J. H., Schneider, J. A., Maxwell, R. A., & Earl, A. E. (1955). Ganglionic blockade by a new bisquaternary series, including chlorisondamine dimethochloride. J. Pharmacol. Exp. Ther. 115, 172-184.
56. Press, H. F., & Maroun, J. A. (1984). The standardization of NK cell assays for use in studies of biological response modifiers. J. Immunol. Methods 68, 235-249.
57. Shavit, Y., DePaulis, A., Martin, F. C., Terman, G. W., Pechnick, R. N., Zane, C. J., Gale, R. P., & Liebeskind, J. C. (1986). Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. USA 83, 7114-7117.
58. Shavit, Y., Martin, F. C., Yirmiya, R., Ben-Eliyahu, S., Terman, G. W., Weiner, H., Gale, R. P., & Liebeskind, J. C. (1987). Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav. Immun. 1, 318-328.
59. Smith, K. A. (1988). Interleukin-2: Inception, impact, and implications. Science 240, 1169-1176.
60. Trunch, A., Albert, F., Goldstein, P., & Schmitt-Verhulst, A. (1985). Early stages of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313, 318-320.
61. Tubaro, E., Borelli, G., Croce, C., Cavallo, G., & Santiangeli, C. (1983). Effect of morphine on resistance to infection. J. Infect. Dis. 148, 656-666.
62. Wakade, A. R. (1988). Noncholinergic transmitter(s) maintains secretion of catecholamines from rat adrenal medulla for several hours of continuous stimulation of splanchnic neurons. J. Neurochem. 50, 1302-1308.
63. Weber, R. J., & Pert, A. (1989). The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245, 188-190.
64. 3H]alprenolol binding. J. Clin. Invest. 57, 149-155.
65. Woods, P. B., & Robinson, M. L. (1981). An investigation of the comparative liposolubilities of β-adrenoceptor blocking agents. J. Pharm. Pharmacol. 33, 172-173.